If the cardiologist is putting in a totally new biventricular system, regardless of whether it's a pacemaker or a defibrillator, you should report the base codes for device insertion and add +33225 ( Don't forget to add this new code, because you could lose out on reimbursement for the left ventricular lead insertion if you overlook it. Since CPT 2003 approved 33225 as an add-on code, which indicates recognition of the specific, additional work involved in inserting new devices with left ventricular leads, coding experts hope payers will recognize this. Some carriers are used to seeing the unlisted-procedure code for cardiology (33999) for left ventricular lead placement and may not recognize 33225. So coders may initially have to explain that this is a new, unique code for what was an unspecified procedure last year, Veath says. Even so, payers would be more likely to deny payment for upgrades with the Y-adapter (33224) than 33225 because the new biventricular devices have FDA approval, she adds. As with other biventricular procedures, physicians need to be very specific about describing in their procedure notes that they inserted and attached the left ventricular lead, or they could risk losing substantial reimbursement, Veath emphasizes. Third Lead Is Crucial in Dual-Chamber Pacers When the new system is a dual-chamber pacemaker, report 33208 ( For insertions of new ICDs, report 33249 ( When the cardiologist removes an old pacemaker, implants a new generator and inserts a left ventricular lead, you should report 33233 ( Like 33224, 33225 includes venography, so you would not report that separately, Collins says. According to parenthetical information accompanying the 33225 description, you should use this code with the following primary pacemaker procedure codes: 33206-33208, 33212-33214, 33216-33217, 33222, 33233-33235, 33240 and 33249. The AMA will likely delete 33206 ( If the physician implants a new generator and adds a Y-adapter to achieve biventricular pacing, report the procedure as you would in the absence of the left ventricular lead, and then add on 33225. This logic holds true for all new generator implantations, Collins says.
Medicare and private payers have provided solid coverage for new biventricular device implantation since the U.S. Food and Drug Administration's (FDA) approval of the InSync biventricular pacing system in 2001, says